Brought to you by 
Merix Bioscience gets $1.9mm in private placement
10 Feb 2000
Executive Summary
Merix Bioscience (develops immunotherapy vaccines to treat metastatic cancers and chronic infectious diseases) has received $1.9mm in a private placement led by Senmed Medical Ventures. Other investors included: Aurora Ventures II LLC, Intersouth Partners IV LP, Bright Mining and Land Company LP, Cordova Capital Partners LP, University Medical Discoveries Inc. (a subsidiary of MDS Health Ventures Capital Corp.), and BD Ventures LLC.
Deal Industry
- Biotechnology
-
Pharmaceuticals
- Vaccines
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Merix Bioscience gets $1.9mm in private placement
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice